FIGO staging for carcinosarcoma: Can the revised staging system predict overall survival?-Reference-Cited by-同舟云学术

FIGO staging for carcinosarcoma: Can the revised staging system predict overall survival?

Published:2011-11 Issue:2 Volume:123 Page:221-224
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Pradhan Tana S.,Stevens Erin E.,Ablavsky Michael,Salame Ghadir,Lee Yi-Chun,Abulafia Ovadia

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference13 articles.

1. Carcinosarcomas (malignant mixed müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics;Kernochan;JNCCN,2009

2. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma;Galaal;Cochrane Database Syst Rev,2011

3. Cancer staging;O'Sullivan;Cancer Prev Control,1998

4. Time-dependent ROC curves for censored survival data and a diagnostic marker;Heagerty;Biometrics,2000

5. A gynecologic oncology group randomized phase III trial of whole abdominal radiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterus;Wolfson;Gynecol Oncol,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordances in expression of human epidermal growth factor receptor 2 between primary and metastatic uterine carcinosarcoma: A proposal for HER2-targeted therapy specimen selection;Annals of Diagnostic Pathology;2023-08

2. Uterine Sarcoma and Carcinosarcoma: A Two-Center Experience in Iran;MIDDLE EAST J CANCER;2023

3. Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy;Clinical Cancer Research;2023-03-28

4. Uterine carcinosarcoma: An overview;Critical Reviews in Oncology/Hematology;2021-07

5. Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy;Virchows Archiv;2021-01-09